Profile
Dr Jordan Fulcher
- Structural Heart Interventional Cardiologist
- Royal Prince Alfred Hospital (Staff Specialist)
- Strathfield Private Hospital (VMO)
- Macquarie University Hospital (VMO)
- Chris O'Brien Lifehouse (VMO)
Dr Jordan Fulcher is an Interventional and Structural Cardiologist with subspecialty expertise in transcatheter valve therapies. He completed his medical training at the University of New South Wales and cardiology advanced training at Royal Prince Alfred Hospital, where he is now a Staff Specialist in Interventional and Structural Cardiology.
Following his general cardiology fellowship, Dr Fulcher undertook dedicated interventional training at the Austin Hospital in Melbourne followed by a Structural Cardiology Fellowship focusing on transcatheter interventions (2018–2020). In 2021, he was awarded the prestigious ANZET-UK Structural Intervention Fellowship, training at Leeds General Infirmary in the United Kingdom under leading transcatheter valve specialists.
Dr Fulcher has a strong academic background, having completed a Masters of Clinical Trials Research and a PhD at the NHMRC Clinical Trials Centre, University of Sydney, investigating cardiovascular risk and lipid-lowering therapies. His research has been published in leading journals including The Lancet and the European Heart Journal. He continues to be actively involved in clinical research, including recently published international trials in structural heart disease such as the SMART Trial and the British Heart Foundation’s PROTECT-TAVI study.
He currently serves on the RPA Hospital Structural Heart Disease Steering Committee and the Medtronic Structural Heart Emerging Leaders Committee. He leads the Structural Heart program at Strathfield Private Hospital.
- Structural heart interventions including Transcatheter aortic valve implantation (TAVI), TEER, ASD/PFO Closure, LAA Occlusion and Renal denervation
- Percutaneous coronary intervention
- Invasive cardiac diagnostics
- Cardiovascular risk and prevention including lipid lowering therapies
- Clinical research and teaching
Hamilton GW, Fletcher LR, Harley W, Azzopardi R, Chan RK, Fulcher J, Miles LF, Farouque O, Horrigan MCG. Differences in Direct Fick and Thermodilution Measurements of Cardiac Output: Impact on Pulmonary Hypertension Classification. Pulmonary Circulation. 2025;15(1):e70053.
https://doi.org/10.1002/pul2.70053
Khandkar C, Fulcher J, Patel S, Keech A. Treatment of vulnerable atherosclerotic plaques: the PREVENT trial. The Lancet. 2024;404(10465):1811-2.
https://doi.org/10.1016/S0140-6736(24)02222-0
Ferguson C, William S, Allida SM, Fulcher J, Jenkins AJ, Lattimore J-D, Loch LJ, Keech A. The Development of Heart Failure Electronic-Message Driven Tips to Support Self-Management: Co-Design Case Study. JMIR Cardio. 2024;8:e57328.
https://doi.org/10.2196/57328
Reith C, Preiss D, Blackwell L, Emberson J, Spata E, Davies K, Halls H, Harper C, Holland L, Wilson K, Roddick AJ, Cannon CP, Clarke R, Colhoun HM, Durrington PN, Goto S, Hitman GA, Hovingh GK, Jukema JW, Koenig W, Marschner I, Mihaylova B, Newman C, Probsfield JL, Ridker PM, Sabatine MS, Sattar N, Schwartz GG, Tavazzi L, Tonkin A, Trompet S, White H, Yusuf S, Armitage J, Keech A, Simes J, Collins R, Baigent C, Barnes E, Fulcher J, Herrington WG,…. Zannad F. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis. The Lancet Diabetes & Endocrinology. 2024;12(5):306-19.
https://doi.org/10.1016/S2213-8587(24)00040-8
Hamilton GW, Dinh D, Yeoh J, Brennan AL, Fulcher J, Koshy AN, et al. Characteristics of Radial Artery Coronary Bypass Graft Failure and Outcomes Following Subsequent Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 2023;16(4):457-67.
https://doi.org/doi:10.1016/j.jcin.2022.11.035
Cholesterol Treatment Trialists (CTT) Collaboration (Reith C, Baigent C, Blackwell L, Emberson J, Spata E, Davies K, Halls H, Holland L, Wilson K, Armitage J, Harper C, Preiss D, Roddick A, Keech A, Simes J, Collins R, Barnes E, Fulcher J, Herrington WG, . . . Yamaguchi, J). Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. The Lancet. 2022; 400(10355), 832-845.
https://doi.org/10.1016/S0140-6736(22)01545-8
Drak D, Fulcher J, Kilian J, Chong JJH, Grover R, Sindone AP, et al. Guideline-based audit of the hospital management of heart failure with reduced ejection fraction. Intern Med J. 2023;53(9):1595-601.
https://doi.org/https://doi.org/10.1111/imj.15830
Chen D, Fulcher J, Scott ES, Jenkins AJ. Precision Medicine Approaches for Management of Type 2 Diabetes. In: Basu R, editor. Precision Medicine in Diabetes: A Multidisciplinary Approach to an Emerging Paradigm. Cham: Springer International Publishing; 2022. p. 1-52.
https://doi.org/10.1007/978-3-030-98927-9_1
Koshy AN, Dinh DT, Fulcher J, Brennan AL, Murphy AC, Duffy SJ, et al. Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary intervention. American Heart Journal. 2022;244:77-85.
https://doi.org/10.1016/j.ahj.2021.10.190
Fulcher J, Keech A, Simes S, Baigent C, Collins R. Questioning statin therapy for older patients – Authors’reply”. The Lancet. 2020;395(10240):1832-1833
https://doi.org/10.1016/S0140-6736(19)33159-9
Sivashanmugarajah A, Fulcher J, Sullivan D, Elam M, Jenkins A, Keech A. Pharmacogenetics of statin intolerance Reply. Internal Medicine Journal. 2020;50(4):507-8
https://doi.10.1111/imj.14785
Hamilton GW, Koshy AN, Fulcher J, Tang GHL, Bapat V, Murphy A, et al. Meta-analysis Comparing Valve-In-Valve Transcatheter Aortic Valve Implantation with Self-Expanding Versus Balloon-Expandable Valves. American Journal of Cardiology. 2020; In press
https://doi.org/10.1016/j.amjcard.2020.02.021
Wang N, Fulcher J, Abeysuriya N, Park L, Kumar S, Di Tanna GL, et al. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants. Lancet Diabetes & Endocrinology. 2020;8(1):36-49.
https://doi: 10.1016/S2213-8587(19)30388-2
Sivashanmugarajah A, Fulcher J, Sullivan D, Elam M, Jenkins A, Keech A. Suggested clinical approach for the diagnosis and management of ‘statin intolerance’ with an emphasis on muscle‐related side‐effects. Internal Medicine Journal. 2019;49(9):1081-91.
https://doi: 10.1111/imj.14429
Cholesterol Treatment Trialists (CTT) Collaboration (Writing committee: Fulcher J*, Mihaylova B*, O’Connell R, Emberson J, Blackwell L, Reith C, Koren M, Tonkin A, Ridker P, Barnes E, Ford I, Packard C, Lonn E, Wanner C, Koenig W, Gotto A, Kjekshus J, Yusuf S, Collins R, Simes J, Baigent C, Keech A (*Contributed equally)). Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. The Lancet 2019; 393:407-415.
https://doi.org/10.1016/S0140-6736(18)31942-1
Wang N, Fulcher J, Abeysuriya N, McGrady M, Wilcox I, Celermajer D, Lal S. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis, European Heart Journal, Volume 40, Issue 5, 01 February 2019, Pages 476–484
https://doi.org/10.1093/eurheartj/ehy641
Wang N, Fulcher J, Abeysuriya N, Adams M, Lal S. Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis. Heart 2018;104:517-524.
https://doi.org/10.1136/heartjnl-2017-311986
Jenkins AJ, Scott E, Fulcher J, Kilov G, Januszewski AS. Management of Diabetes Mellitus. In: Toth P, Cannon C, editors. Comprehensive Cardiovascular Medicine in the Primary Care Setting, Contemporary Cardiology. Springer Nature Switzerland AG; 2019.
https://doi.org/10.1007/978-3-319-97622-8
Cholesterol Treatment Trialists (CTT) Collaboration (Writing committee: William G Herrington*, Jonathan Emberson*, Borislava Mihaylova*, Lisa Blackwell, Christina Reith, Marit D Solbu, Patrick B Mark, Bengt Fellström, Alan G Jardine, Christoph Wanner, Hallvard Holdaas, Jordan Fulcher, Richard Haynes, Martin J Landray, Anthony Keech, John Simes, Rory Collins, and Colin Baigent (*Contributed equally)). Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes & Endocrinology. 2016;4(10):829-39.
https://doi.org/10.1016/S2213-8587(16)30156-5
Abed HS, Fulcher JR, Kilborn MJ, Keech AC. Inappropriate sinus tachycardia: focus on ivabradine. Internal Medicine Journal. 2016;46(8):875-83.
https://doi.org/10.1111/imj.13093
Fulcher J*, Chia N*, Keech A. Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID(2) ): an evidence-based mnemonic for the treatment of systolic heart failure. Internal Medicine Journal. 2016;46(6):653-62. (*Co-first authors)
https://doi.org/10.1111/imj.12839
Cholesterol Treatment Trialists (CTT) Collaboration (Writing committee: Reith C., Blackwell L., Emberson J.,Mihaylova B.,Armitage J., Fulcher J., Keech A., Simes J., Baigent C., Collins R. Protocol for analyses of adverse event data from randomized controlled trials of statin therapy. American Heart Journal. 2016;176:63-9.
https://doi.org/10.1016/j.ahj.2016.01.016
Fulcher J, Patel S, Nicholls SJ, Bao S, Celermajer D. Optical coherence tomography for serial in vivo imaging of aortic plaque in the rabbit: a preliminary experience. Open Heart. 2015;2(1):e000314.
https://doi.org/10.1136/openhrt-2015-000314
Cholesterol Treatment Trialists’ (CTT) Collaboration (Writing committee: Fulcher J*, O’Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, La Rosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C*, Keech A* (*Contributed equally)). Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. The Lancet 2015; 385: 1397-1405
https://doi.org/10.1016/s0140-6736(14)61368-4
Fulcher J*, Chin J*, Jenkins A, Keech A. Is it Time to Repair a Fairly Fast SAAB Convertible? Testing an Evidence-based Mnemonic for the Secondary Prevention of Cardiovascular Disease. Heart Lung & Circulation 2015; 24(5): 480-487. (* Co-first authors)
https://doi.org/10.1016/j.hlc.2014.11.016
Fulcher J, Keech A. Aspirin Use in People with Diabetes: The Evidence. Diabetes Management: A Journal for General Practitioners and Other Health Professionals 2013; 45: 20-24
Fulcher J, Wilcox I. Basal Stress Cardiomyopathy Induced by Exogenous Catecholamines in Younger Adults. International Journal of Cardiology 2013; 168 (6): e158-e160.
https://doi.org/10.1016/j.ijcard.2013.08.067
Keech AC, Fulcher JR, Simes J. The role of statin therapy in patients with lower vascular risk. Medical Journal of Australia 2012; 197 (3): 130-131.
https://doi.org/10.5694/mja12.10925
Fulcher J, Keech A. The case for more intensive use of statins. Therapeutic Advances in Chronic Disease 2012; 3: 201-210
https://doi.org/10.1177/2040622312454045